RENOVARO INC. (RENB)
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Address
CENTURY CITY MEDICAL PLAZA
SUITE 906 LOS ANGELES, CA 90067
Founded
2011
Number of Employees
12
Website
http://renovarobio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)